- Investing Ideas
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Abbott India
Market Cap: ₹576.4b
Operates as a pharmaceutical company in India.
500488
₹27,384.30
7D
2.0%
1Y
-20.4%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹412.6b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,417.30
7D
0.7%
1Y
-24.2%
Sanofi India
Market Cap: ₹78.5b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,342.80
7D
-3.0%
1Y
-43.6%